1. Trang chủ
  2. » Tất cả

914 gene expression profiles in skeletal muscle after DNA electrotransfer indicate a highly efficient and safe gene therapy platform

2 3 0

Đang tải... (xem toàn văn)

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Tiêu đề 914 Gene Expression Profiles in Skeletal Muscle After DNA Electrotransfer Indicate a Highly Efficient and Safe Gene Therapy Platform
Tác giả R. Scott Mcivor, Erik R. Olson, Alice Hsu, Kerri Bostrom, Susan Sonntag, Kurt Lalsresh, Jason Bell, Perry B. Hackett
Trường học University of Minnesota
Chuyên ngành Gene Therapy
Thể loại Research Article
Năm xuất bản 2006
Thành phố Minneapolis
Định dạng
Số trang 2
Dung lượng 1,06 MB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

914 Gene Expression Profiles in Skeletal Muscle after DNA Electrotransfer Indicate a Highly Efficient and Safe Gene Therapy Platform 912 Canine Erythropoietin as a Secreted Reporter System for the Stu[.]

Trang 1

912 Canine Erythropoietin as a Secreted

Reporter System for the Study of Sleeping

Beauty-Mediated Long-Term Expression in the

Dog

R Scott Mcivor,' Erik R Olson,1Alice Hsu,' KerriBostrom,'

Susan Sonntag,' Kurt Lalsresh,'Jason Bell,' Perry B Hackett.'

I Discovery Genomics, lnc , Minneapolis, MN; lR&D Systems ,

Minneapolis, MN; JGenetics, Cell Biology and Development,

University ofMinnesota, Minneapolis, MN.

The Sleeping Beauty transposon system (SB) has been

demon-strated to mediate non-viral integration and long-term expression of

several reporter genes as well as therapeutic genes in mice.Our goal

is to test the effectiveness of SB in achieving long-term expression

of therapeutic genes in the dog as a large animal model for gene

therapy in humans We previously reported murine erythropoietin

(EPO) as a convenient reporter for which long-term expression can

be monitored using a sensitive enzyme-linkedimmunosorbant

as-say(ELISA) for analysisofblood samples regularly collected from

mice treated with murine EPO-encoding transposons (Molecular

Therapy 13: 617,2006) To adapt this system for monitoring ofgene

expression in the dog, the canine EPO coding sequence was isolated

from a canine cDNA library To test the effectiveness of the eEPO

sequence as a reporter for in vivostudies,a CMV-regu!ated cEPO

construct was tested by transfection into human HEK 293 cells and

by hydrodynamic injectionintoC57BL/6mice Supernatants from

the transfected 293 cells contained substantial levels ofmaterial that

was immunoreactive in the human EPO ELISA, demonstrating the

effectiveness ofthis assay for monitoring expression ofcanine EPO

Plasma prepared from blood collected 24 hours after injection ofthc

animals also contained substantiallcvels ofimmunorcactive canine

EPO,detectable by ELISA Blood samples collected one week

post-injection showed a substantial increase in hematocrit (from 50

up to a range of 64 to 70), demonstrating the biological activity of

cEPO when expressed in mice after hydrodynamic injection of the

CMV-regulated construct These results verify that canine EPO can

be used as a sensitive secretable reporter that is detectable by ELISA

of plasma samples, and that the mouse can be used as a test system

for cEPO expression and biological activity One of the problems

encountered in long-term expression of biologically active EPO is

a severe erythrocytosis that can be lethal for the test animal Based

on structure-function studies reported for human EPO variants

gen-erated by site-directed mutagenesis, we constructed several canine

EPO variants bearing amino acid substitutionspredicted to confer

reduced biological activity while maintaining immunoreactivity in

the human EPO ELISA CMV-regulatcd plasm ids encoding these

cEPO variantswere hydrodynamically injected into C57BLl6 mice,

assaying for immunoreactive material byELISA and for biological

activity by increased hematocrit We found that the S lODE form

of cEPO was undetectable by ELISA, but was also biologically

inactive However,the G 145A and K45D variants of cEPO both

exhibited reduced biological activity while immunoreactivity was

largely retained ThesecEPO variants will provide useful reporters

for studies in the dog should long-term expression ofwild-type cEPO

prove to cause health problems for the testing of SB transposons in

this large animal system

913 Aerosol Gene Delivery to the Lungs of

Mice Guided by Magnetic Forces

Petra Dames,' Eugenia Lesina,1Carsten Rudolph.'

I Pediatrics , Ludwig Maximilians University, Munich , Germany.

Magnetic drug targeting has been previously investigated for

site-specific drug delivery to improve therapeutic efficiency In our

study, weapplied magnetic drug targeting to aerosol gene delivery

to the lungs ofmice by application ofan external magnetic field

dur-S348

ing aerosol application of polyethylen imine (PEI)-pDNA particles

in combination with superparamagnetic iron oxide nanoparticles (SPION) In previous inhalation studies in mice, we found that

inhaled aerosol droplets containing SPIONs could be enriched in lungs when an electromagnet was positioned above the lung during inhalation Deposition rates ofco-delivered plasmid DNA correlated with SPION deposition, In this study, we examined gene expression

in the lungs after aerosol delivery guided by magnetic forces using pDNA coding for firefly luciferase Additionally, pDNA deposition in mice lungs was quantified by real time PCR.Branched PEl (25kDa)-pDNA complexes together with SPIONs were applied to mice placed

in a whole-body nebulization device As an external magnetic field

a small cubic (10 mm3) permanent magnet was fixed on the fur of mice above the lungs with tissue glue After aerosol application of SPIONs coated with PEl (12.5 mgml-I) and co-delivery of PEI-pDNA complexes (0.1 mgml-I, 125:1),we detected 4-fold higher luciferase expression in mice lungs with than without magnetic field application But expression was 7.5-fold lower compared to PEI-pDNA aerosol application Therefore,we performed in vitro experiments co-transfecting BEAS-2B cells with PEI-pDNA and SPIONs at different ratios As observed in vivo, luciferase expres-sion was deereascd compared to PEI-pDNA transfection at high SPION/pDNA ratios But expression was increased about 2-fold by magnetic forces when lower ratios ofSPIONs to pDN A (15: I) were used Further in vivo experiments were performed using PEI-pONA (0.2 mgml-l ) and lower concentration ofSPIONs (3.0 mgml-l ),We detected a 1.5-fold increase ofpDNA deposition whcn an external magnetic field was applied, but we could not measure any luciferase expression in mice lungs with IVIS 100 imaging system (Xenogen, Alameda, CA) In conclusion, we suggest that it is in principal possible to enhance pDNA deposition and gene expression in mice lungs after aerosol delivery by magnetic forces, but further efforts are necessary to increase gene expression in future

914 Gene Expression Profiles in Skeletal Muscle after DNA Electrotransfer Indicate a Highly Efficient and Safe Gene Therapy Platform

John R Zibert,' Pernille H.Moller,'JensEriksen.i Julie GehJ.2

I Department 0/ Derm atology, Copenhagen University Ho spital

Gentofle, Hellerup, Denmark; lLaboratOly ofthe Department ofOncology, Copenhagen University Hospital Herlev, Herlev, Denmark

Background :Gene transfer by e1ectroporation (DNA elcctrotrans-fer) to muscles results in high lcvcllong term transgenic expression, showing great promises for systemic treatments of e.g cancers and protein deficiency syndromes However, little is known about the adverse effects of DNA electrotransfer on muscle fibres We have therefore investigated transcriptional changes through gene expres-sion profile analyses, as well as morphological changes evaluated

by histological analysis.DNA eleetrotransfer was obtained using

a combination of a short high voltage pulse (HV, 1000 V/cm, 100 us) followed by a long low voltage pulse (LV, 100 V/cm, 400 ms);

a pulse combination optimised for safe and efficient gene transfer Muscles were transfeeted with green fluorescent protein (GFP) and excised at 4 hours, 48 hours or 3 weeks after treatment.Results:

Differentially expressed genes were investigated by microarray analysis, and descriptivestatistics were performed to evaluate the effects of I) electroporation, 2) DNA injection,and 3) time after treatment The biological significance of the results was assessed

by gene annotation and supervised cluster analysis and validated

by quantitative RT-PCR Generally,electroporation alone caused

down-regulation of structural proteins e.g sareospans and cata-lytic enzymes such as phosphoenolpuryvate carboxykinases, DNA injection alone induced down-regulation of intracellular transport proteins e.g.sentrins Three weeks after treatment, the injection of

Molecul ar Therapy Volume15 Supplement I, \by 2007

Co pyright © '111C Am erican Soc iety o f G ene Tl lcr.lpr

Trang 2

DNA and eleetroporation was clustering together with injection of

DNA alone and e1ectroporation alone and was furthermore

cluster-ing very close to the untreated controls This indicates a safe gene

therapy platform with transient effects on the muscle fibres after

three weeks (see the figure)

EP

DNA Time

Most interestingly, no changes in the expression of proteins

involved in inflammatory responses or muscle regeneration was

detected,indicating limited muscle damage and regeneration The

morphological changes indicated structural changes with loss ofcell

integrity and striation pattern in some fibres after DNA injection

and electroporation treatment, while electroporation alone caused

minor loss of striation pattern but preservation of cell integrity

Conclusion: The small and transient changes found in the gene

expression profiles arc of great importance, as this indicates that

DNA electrotransfer is safe with minor effects on the muscle host

cells Certainly the I-1V+LV pulse combination used have been

opti-mised to ensure highly efficient and safe DNAelectrotransfer;These

findings are essential for introducing this gene therapy platform in

the clinic with focus on systemic treatment regimes for a variety of

diseases like cancers

915 Controlled Long-Lasting Hematocrit

Increase by EPO Plasmid Electrotransfer

Emmanuelle Fabre,' Daniel Scherman; Pascal Bigey.'

'INSERM U640; CNRS UMR8151; Chemical and Genetic

Pharmacology Laboratory University Paris Descartes, Ecole

Nationale Superieure de Chimie de Paris; INSERM; CNRS,

Paris, France.

The potential applications of gene transfer include gene therapy,

DNA vaccination or gene functional study According to the desired

application,different level, kinetics and localization of gene

ex-pression might be required In this original and unpublished work,

we describe a way of reaching a stable level of hematocritin beta

thalassemic mice after several electrotransfer treatments with low

doses of EPO encoding DNA plasmid Our results suggest that a

therapeutic level of EPO can be reached,inducing an almost nor

-mal hematocrit in sick mice,and avoiding a deleterious hematocrit

Molecular Therapy Volume IS S upplement 1 ~by 20

C op yright © T he Am eric m Society o r Gene Therapy

peak after treatment More generally,this strategy could be applied for functional studies of any given circulating protein instead of generating transgenic animals

916 Muscle Characteristics Affect Plasmid Expression Following Electroporation in Both Large and Small Animals

Patricia A Brown,' Amir S Khan; Melissa A Pope,IRuxandra Draghia-Akli.'

'VGX Pharmaceuticals, Immune Therapeutics Division, The Woodlands, TX

In vivo electroporation (EP) has been established as a simple,

efficient and reproducible method for the intramuscular delivery of therapeutic plasm ids, DNA vaccines,oligonucleotides, and siRNA Expression levels are increased by several orders of magnitude with EP over 1M injection alone Obtaining the optimal expression

in animal models involves taking into account several different variables, including: animal species and age, plasmid size, and components of the expression cassette and backbone, plasmid formulation and concentration, and electroporation conditions However,pre-clinical studies outlining the effect ofmuscle type(i e

fiber type composition) and its characteristics (fat and fiber content versus muscle fiber content) have not been well described inthe literature While muscles in smaller animals such as the rodent can have predominantly one type of fiber types (type I,type II and its subtypes), larger animals have mostly mixed fiber types muscles; nevertheless fiber type percentage may change during development and/or activity and training Our recent studies have indicated that the choice ofmuscle lor injection and EP is vital to obtain the highest possible plasmid expression levels A reporter plasmid expressing secreted embryonic alkaline phosphatase (SEAP) was administered

to mice indifferentmuscles,including tibialis anterior (predomi-nantly type II fibers) or quadriceps muscle (mixed muscle) Serum SEAP levels were over 50% higher (p==0.002) when the plasmid was administered in the tibialis muscle When the footpad of mice was injected and electroporated,the flexor digitorum brevis muscle fibers expressed well the plasmid,while only low expression was detected in the interstitial fat and conjunctive tissue Splenius, pectoralis,and semitendinosus muscles in young horses were ad-ministered the SEAP plasmid loll owed by identical conditions of electroporation Pectoralis muscle obtained the highest expression

at Day 21,and correlated with a predominance of type ([ fibers in these well trained horse (more than twice as high as the splenius and ten times the levels achieved in the semitendinosus) In a previous study in pigs, a series of muscles (semitendinosus, sternocranialis, longissimus dorsi, brachialis, masseter,and footpad) were injected with SEAP-expressing plasmid at identical conditions Longissimus dorsi yielded higher expression as compared to semitendinosus,

sternocranialis and brachialis Transfection of masseter (15-30% type I fibers) and footpad muscles yielded the lowest expression The EP used in these studies was preformed using a constant current electroporation (CCE) device The results ofstudies suggest that the careful choice oftarget muscle for transfection with vaccine and/or therapeutic plasm ids in clinical studies is critically important and that CCE can be used to deliver these vectors successfully

S349

Ngày đăng: 19/11/2022, 11:36

TỪ KHÓA LIÊN QUAN

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

🧩 Sản phẩm bạn có thể quan tâm

w